Controlled trials with bromocriptine and memantine have notyielded positive results.63,64 Although many patients with PPAmay have atypical AD, cholinesterase inhibitors have not been particularly useful.However, a new trial of these agents, specifically in patients with the biomarkersof AD, would be useful to initiate. The gene discussed is BCHE; the disease is Alzheimer disease.